Reporting of health‐related quality of life endpoints in National Cancer Institute–supported cancer treatment trials-Reference-Cited by-同舟云学术

Reporting of health‐related quality of life endpoints in National Cancer Institute–supported cancer treatment trials

Published:2020-04 Issue:11 Volume:126 Page:2687-2693
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

St Germain Diane¹,Denicoff Andrea²,Torres Andrea³^ORCID,Kelaghan Joseph¹,McCaskill‐Stevens Worta¹,Mishkin Grace²,O’Mara Ann¹,Minasian Lori M.¹^ORCID

Affiliation:

1. Division of Cancer Prevention National Cancer Institute Bethesda Maryland

2. Division of Cancer Treatment and Diagnosis National Cancer Institute Bethesda Maryland

3. Health, Environment, Analytics, Resilience & Social Group ICF Fairfax Virginia

Funder

ICF

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32765

Reference25 articles.

1. National Cancer Institute.What are clinical trials?Updated June 2016. Accessed November 5 2018.https://www.cancer.gov/about-cancer/treatment/clinical-trials/what-are-trials

2. Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials

3. Quality-of-Life Assessment in the Symptom Management Trials of the National Cancer Institute-Supported Community Clinical Oncology Program

4. Lessons Learned in the Assessment of Health-Related Quality of Life: Selected Examples From the National Cancer Institute of Canada Clinical Trials Group

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study;Journal of Clinical Oncology;2024-07-26

2. The impact of clinical and translational research on the quality of life during the metastatic colorectal cancer patient journey;Frontiers in Oncology;2023-10-16

3. Fundamentals of Conducting Cooperative Group Trials Through the National Clinical Trials Network;Surgical Oncology Clinics of North America;2023-01

4. Clinician and Patient Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: Using CTCAE and PRO-CTCAE® to Provide Two Distinct and Complementary Perspectives;Patient Related Outcome Measures;2022-12

5. Listening to the Patient Voice Adds Value to Cancer Clinical Trials;JNCI: Journal of the National Cancer Institute;2022-07-28